Exelixis
EXEL
#1686
Rank
A$15.56 B
Marketcap
$54.52
Share price
2.24%
Change (1 day)
65.50%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $75.40 AUD on 2000-07-26

Lowest end of day price: $1.98 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$51.99 0.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
$73.92 0.63%๐Ÿ‡ซ๐Ÿ‡ท France
$151.85-0.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$90.13 1.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$450.93 1.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$237.57-0.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$39.27 2.07%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.17-1.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.97 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA